Eba Hathout, MD

Attending Physician, Division of Endocrinology
Faculty, Harvard Medical School
Image
Eba Hathout, MD

Eba Hathout, MD

Attending Physician, Division of Endocrinology
Faculty, Harvard Medical School

Medical Services

Languages
Arabic
English
French
Spanish
Education
Medical School
Faculty of Medicine, Kuwait University
Jabriya
Kuwait
Residency
Pediatrics
University of California at Irvine
Irvine
CA
Fellowship
Pediatric Endocrinology
University of California Los Angeles
Los Angeles
CA
Certifications
American Board of Pediatrics (Endocrinology)

Publications

Partial hepatectomy improves the outcome of intraportal islet transplantation by promoting revascularization. View Abstract
Nerve growth factor is associated with islet graft failure following intraportal transplantation. View Abstract
A pathway to insulin independence in newborns and infants with diabetes. View Abstract
Hyperbaric oxygen therapy improves early posttransplant islet function. View Abstract
Bone marrow cell cotransplantation with islets improves their vascularization and function. View Abstract
Correlation between angiogenesis and islet graft function in diabetic mice: magnetic resonance imaging assessment. View Abstract
Bone marrow cells produce nerve growth factor and promote angiogenesis around transplanted islets. View Abstract
Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. View Abstract
Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging. View Abstract
Factors affecting islet graft embolization in the liver of diabetic mice. View Abstract
Factors affecting islet graft embolization in the liver of diabetic mice. View Abstract
MRI assessment of ischemic liver after intraportal islet transplantation. View Abstract
Efficacy comparison between intraportal and subcapsular islet transplants in a murine diabetic model. View Abstract
In vivo imaging demonstrates a time-line for new vessel formation in islet transplantation. View Abstract
Post-transplant diabetes mellitus in pediatric liver transplantation. View Abstract
In vivo magnetic resonance imaging of vascularization in islet transplantation. View Abstract
Dynamic production of hypoxia-inducible factor-1alpha in early transplanted islets. View Abstract
Treatment of hyperglycemia in a 7-year-old child diagnosed with neonatal diabetes. View Abstract
Air pollution and type 1 diabetes in children. View Abstract
Cardiac allograft vasculopathy in pediatric heart transplant recipients. View Abstract
In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. View Abstract
Beneficial effects of nerve growth factor on islet transplantation. View Abstract
Home use of the GlucoWatch G2 biographer in children with diabetes. View Abstract
Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. View Abstract
Growth after heart transplantation. View Abstract
Familial juvenile autoimmune hypothyroidism, pituitary enlargement, obesity, and insulin resistance. View Abstract
Pediatric post-transplant diabetes: data from a large cohort of pediatric heart-transplant recipients. View Abstract
Islet transplant: an option for childhood diabetes? View Abstract
Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. View Abstract
How should we interpret "real life" conditions. View Abstract
Effect of therapy with insulin glargine (lantus) on glycemic control in toddlers, children, and adolescents with diabetes. View Abstract
Glycemic, auxologic, and seasonal aspects of continuous subcutaneous insulin infusion therapy in children and young adults with type 1 diabetes. View Abstract
Role of exposure to air pollutants in the development of type 1 diabetes before and after 5 yr of age. View Abstract
Use of the GlucoWatch biographer in children and adolescents with diabetes. View Abstract
Diabetic autoimmune markers in children and adolescents with type 2 diabetes. View Abstract
Diabetic autoimmunity in infants and pre-schoolers with type 1 diabetes. View Abstract
Suprasellar dysplasia: a pediatric perspective. View Abstract
Changes in plasma leptin during the treatment of diabetic ketoacidosis. View Abstract
Normal growth despite GH, IGF-I and IGF-II deficiency. View Abstract
A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea. View Abstract
Association of terminal chromosome 1 deletion with sertoli cell-only syndrome. View Abstract
Hemifacial microsomia and abnormal chromosome 22. View Abstract
Absence of GLUT2 protein in near-term fetal rat pancreatic islets. View Abstract